Table 2 Recent depletion studies comparing acute tryptophan depletion drink with amino acid balance drink (sham drink) - characteristics and results.

From: The serotonin theory of depression: a systematic umbrella review of the evidence

Study

Randomised controlled trial design

Participants: Healthy volunteers (HV) or people with depression*

Medication status

Summary effect (95% CI), p

Frey & McCabe, 2020

Parallel group, double blind

46 HV

No psychotropic medication for at least 3 months

No effect

Bar et al., 2020

Crossover trial, double blind

30 HV

Not specified

No effect

Deza-Araujo et al., 2018

Crossover trial, double blind

85 HV

Not specified

No effect

Martin et al., 2017

Crossover trial, double blind

15 HV

No history of neurological or psychiatric disorders

No effect

Eisner et al., 2016

Crossover trial, double blind

64 HV

No history of neurological or psychiatric disorders

No effect

Trotter et al., 2016

Parallel group, double blind

30 HV

Not specified

No effect

Hogenelst 2016

Crossover trial, double blind

40 HV with or without a family history of MDD

‘No use of psychotropics’

No effect

Weinstein et al., 2015

Crossover trial, double blind

15 people with depression

Treated with sertraline for 12 weeks prior to study

No effect

Moreno et al., 2015

Crossover trial, double blind

64 people with personal and family history of MDD; in remission

No ‘psychotropic medication’ for at least 3 months prior to test

A significant main effect of test condition (χ 2 = 5.14, d.f. = 1, p = 0.023) mainly due to improvement of HDRS scores following sham drink

Hembold et al., 2013

Crossover trial, double blind

18 HV

Not specified

No effect

  1. MDD Major Depressive disorder, HDRS Hamilton depression rating scale.
  2. *sample size has a different meaning in crossover studies since each participant contributes data twice.